GSK3B and glioblastoma: Although the detailed mechanism of RPN2 mediated regulation for wnt/β-catenin pathway remains to be further elucidated, all the data indicate that RPN2-mediated GSK-3β/wnt/β-catenin/AKT1 loop network dysregulation plays critical roles in GBM progression and TMZ resistance.